As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Featured review: Allergic diseases in the elderly
Life expectancy and the number of elderly people are progressively increasing around the world. Together with other pathologies, allergic diseases also show an increasing incidence in geriatric age.
This review provides the state of the art on the physiological changes in the elderly responsible for allergic diseases, their biological characteristics and the major immunological and extra immunological mechanisms.
Articles
-
-
Vitamin D and Covid-19: an update on evidence and potential therapeutic implications
-
Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management
-
Oral health in asthmatic patients: a review
-
Physicians’ prescribing behaviour and clinical practice patterns for allergic rhinitis management in Italy
-
Autoimmune progesterone dermatitis in a patient with endometriosis: case report and review of the literature
-
Incense smoke: clinical, structural and molecular effects on airway disease
-
Dermatology for the practicing allergist: Tinea pedis and its complications
-
Food hypersensitivity by inhalation
-
Vitamin D and Covid-19: an update on evidence and potential therapeutic implications
Aims and scope
Clinical and Molecular Allergy is an open access, peer-reviewed journal that covers all aspects of allergy research with a special focus on molecular allergy and clinical applications of molecular techniques. Clinical and Molecular Allergy is the official journal of the Italian Society of Allergology, Asthma and Clinical Immunology.
This international journal appeals to allergists & immunologists, pulmonologists, otolaryngologists, geneticists and other physicians, healthcare workers, medical students and the public worldwide.
The journal accepts research articles, reviews, commentaries, case reports and correspondence and has six different sections.
Editorial Board
Editor-in-Chief
Enrico Maggi, University of Firenze, Italy
Deputy Editor
Cristoforo Incorvaia, ICP Hospital Milano, Italy
Section Editors
Allergen Immunotherapy
Gianenrico Senna, University-Hospital of Verona, Italy
Giovanni Passalacqua, University of Genoa, Italy
Biologicals
Carlo Agostini, University of Padova, Italy
Alessandra Vultaggio, Careggi University Hospital, Italy
Clinical Immunology
Sebastiano Gangemi, Messina University Hospital, Italy
Massimo Triggiani, University of Salerno, Italy
Food, Drug, Insect Allergy
Elide Pastorello, University of Milano, Italy
Eleonora Salvi, Guglielmo da Saliceto Hospital, Italy
Respiratory Allergy
Marcello Cottini, Papa Giovanni XXIII New Hospital of Bergamo, Italy
Carlo Lombardi, Poliambulanza Hospital, Brescia, Italy
Translational Allergy
Enrico Heffler, University of Catania, Italy
Eustachio Nettis, University of Bari, Italy
About the SIAAIC
The Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) is a scientific society strongly represented on the national territory with more than 650 active members working in university structures, hospital departments and territorial outpatients' clinics.
The main aim of SIAAIC is to improve allergy and clinical immunology as a discipline, through integrated actions of specialistic and post-specialistic education, promotion of knowledge in allergy and clinical immunology, and support of patients' organizations. These aspects are accomplished by giving the opportunity to its members (a third of which are Junior Members, under 35 years of age) to attend several educational events, participate in clinical/epidemiological research and patients-targeted informative events.
Moreover, many active SIAAIC members are worldwide well-known scientists and contribute to increase the knowledge in allergy and clinical immunology into the international scientific community.
The official journal of the Italian Society of Allergology, Asthma and Clinical Immunology (SIAAIC)
Annual Journal Metrics
-
Speed
92 days to first decision for reviewed manuscripts only
92 days to first decision for all manuscripts
181 days from submission to acceptance
19 days from acceptance to publicationCitation Impact
1.347 - Source Normalized Impact per Paper (SNIP)
0.832 - SCImago Journal Rank (SJR)
5.700 - CiteScoreUsage
147,164 Downloads
23 Altmetric mentions
